US Stock MarketDetailed Quotes

NBIX Neurocrine Biosciences

Watchlist
  • 126.790
  • -1.430-1.12%
Close Dec 12 16:00 ET
  • 126.790
  • 0.0000.00%
Post 20:01 ET
12.84BMarket Cap33.81P/E (TTM)

Neurocrine Biosciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-25.47%158M
-64.03%64.6M
204.07%130.3M
14.88%389.9M
-13.64%123.5M
114.57%212M
30.05%179.6M
-209.14%-125.2M
32.32%339.4M
3,304.76%143M
Net income from continuing operations
56.20%129.8M
-31.94%65M
156.66%43.4M
61.62%249.7M
65.96%147.7M
21.31%83.1M
665.09%95.5M
-651.08%-76.6M
72.43%154.5M
1,319.18%89M
Operating gains losses
----
----
----
----
----
----
----
----
--70M
--0
Depreciation and amortization
18.18%6.5M
43.14%7.3M
24.00%6.2M
36.54%21.3M
29.55%5.7M
37.50%5.5M
30.77%5.1M
51.52%5M
43.12%15.6M
46.67%4.4M
Deferred tax
-730.95%-34.9M
0.48%-41.3M
50.63%-15.6M
-396.86%-56.7M
52.59%20.6M
-146.67%-4.2M
-1,238.71%-41.5M
-10,433.33%-31.6M
344.19%19.1M
387.23%13.5M
Other non cash items
-65.04%-20.3M
25,050.00%49.9M
92,200.00%92.1M
-112.50%-200K
616.67%12.4M
-1,466.67%-12.3M
-110.53%-200K
-108.33%-100K
-88.81%1.6M
61.90%-2.4M
Change In working capital
-90.43%4.4M
-192.40%-86.3M
45.04%-31.6M
141.84%28.2M
-3,480.00%-53.7M
394.87%46M
267.72%93.4M
24.04%-57.5M
-503.59%-67.4M
-130.61%-1.5M
-Change in receivables
57.57%-12.9M
-519.05%-17.6M
72.90%-11.3M
44.94%-89.3M
53.98%-21.4M
-36.94%-30.4M
127.10%4.2M
46.54%-41.7M
-471.13%-162.2M
-114.29%-46.5M
-Change in inventory
-213.79%-3.3M
-431.25%-5.3M
-38.89%1.1M
307.69%5.4M
-123.08%-900K
137.66%2.9M
633.33%1.6M
20.00%1.8M
-4.00%-2.6M
178.00%3.9M
-Change in payables and accrued expense
-68.33%39.4M
-467.28%-59.5M
-377.61%-18.6M
-43.89%64.3M
-320.74%-83M
279.27%124.4M
-50.46%16.2M
-41.74%6.7M
101.76%114.6M
96.86%37.6M
-Change in other working capital
63.06%-18.8M
-105.46%-3.9M
88.48%-2.8M
377.91%47.8M
1,374.29%51.6M
-175.14%-50.9M
740.00%71.4M
-127.10%-24.3M
-86.96%-17.2M
-72.00%3.5M
Cash from discontinued investing activities
Operating cash flow
-25.47%158M
-64.03%64.6M
204.07%130.3M
14.88%389.9M
-13.64%123.5M
114.57%212M
30.05%179.6M
-209.14%-125.2M
32.32%339.4M
3,304.76%143M
Investing cash flow
Cash flow from continuing investing activities
125.39%24.7M
77.60%-28.2M
-30.64%-55M
-163.75%-467.1M
-74.57%-201.8M
-58.73%-97.3M
-500.96%-125.9M
-33.23%-42.1M
-36.02%-177.1M
-587.76%-115.6M
Capital expenditure reported
-6.58%-8.1M
-70.59%-11.6M
-31.76%-11.2M
-71.52%-28.3M
-200.00%-5.4M
-547.06%-7.6M
22.73%-6.8M
-11.84%-8.5M
29.49%-16.5M
79.78%-1.8M
Net business purchase and sale
----
----
----
--0
----
----
----
----
---42.7M
----
Net investment purchase and sale
136.57%32.8M
86.06%-16.6M
-30.36%-43.8M
-272.18%-438.8M
-176.23%-196.4M
-42.38%-89.7M
-396.27%-119.1M
-40.00%-33.6M
-10.39%-117.9M
-318.10%-71.1M
Cash from discontinued investing activities
Investing cash flow
125.39%24.7M
77.60%-28.2M
-30.64%-55M
-163.75%-467.1M
-74.57%-201.8M
-58.73%-97.3M
-500.96%-125.9M
-33.23%-42.1M
-36.02%-177.1M
-587.76%-115.6M
Financing cash flow
Cash flow from continuing financing activities
40.43%26.4M
-10,203.45%-293M
752.44%69.9M
127.87%65.3M
43.90%35.4M
64.91%18.8M
101.05%2.9M
34.43%8.2M
-955.11%-234.3M
1,266.67%24.6M
Net issuance payments of debt
--0
----
----
--0
--0
--0
----
----
-278,900.00%-279M
--0
Proceeds from stock option exercised by employees
40.43%26.4M
444.83%15.8M
752.44%69.9M
46.09%65.3M
43.90%35.4M
64.91%18.8M
11.54%2.9M
34.43%8.2M
62.55%44.7M
1,266.67%24.6M
Cash from discontinued financing activities
Financing cash flow
40.43%26.4M
-10,203.45%-293M
752.44%69.9M
127.87%65.3M
43.90%35.4M
64.91%18.8M
101.05%2.9M
34.43%8.2M
-955.11%-234.3M
1,266.67%24.6M
Net cash flow
Beginning cash position
-12.19%147.7M
262.28%404.3M
-4.29%259.1M
-21.31%270.7M
37.14%301.7M
-1.69%168.2M
-59.86%111.6M
-21.31%270.7M
80.77%344M
-30.00%220M
Current changes in cash
56.63%209.1M
-553.36%-256.6M
191.26%145.2M
83.47%-11.9M
-182.50%-42.9M
173.01%133.5M
152.95%56.6M
-141.06%-159.1M
-146.84%-72M
75.08%52M
Effect of exchange rate changes
----
----
----
123.08%300K
--300K
----
----
----
---1.3M
----
End cash Position
18.36%357.1M
-12.19%147.7M
262.28%404.3M
-4.29%259.1M
-4.29%259.1M
37.14%301.7M
-1.69%168.2M
-59.86%111.6M
-21.31%270.7M
-21.31%270.7M
Free cash flow
-26.66%149.9M
-69.33%53M
189.08%119.1M
11.99%361.6M
-16.36%118.1M
103.38%204.4M
33.64%172.8M
-177.96%-133.7M
38.52%322.9M
3,104.26%141.2M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -25.47%158M-64.03%64.6M204.07%130.3M14.88%389.9M-13.64%123.5M114.57%212M30.05%179.6M-209.14%-125.2M32.32%339.4M3,304.76%143M
Net income from continuing operations 56.20%129.8M-31.94%65M156.66%43.4M61.62%249.7M65.96%147.7M21.31%83.1M665.09%95.5M-651.08%-76.6M72.43%154.5M1,319.18%89M
Operating gains losses ----------------------------------70M--0
Depreciation and amortization 18.18%6.5M43.14%7.3M24.00%6.2M36.54%21.3M29.55%5.7M37.50%5.5M30.77%5.1M51.52%5M43.12%15.6M46.67%4.4M
Deferred tax -730.95%-34.9M0.48%-41.3M50.63%-15.6M-396.86%-56.7M52.59%20.6M-146.67%-4.2M-1,238.71%-41.5M-10,433.33%-31.6M344.19%19.1M387.23%13.5M
Other non cash items -65.04%-20.3M25,050.00%49.9M92,200.00%92.1M-112.50%-200K616.67%12.4M-1,466.67%-12.3M-110.53%-200K-108.33%-100K-88.81%1.6M61.90%-2.4M
Change In working capital -90.43%4.4M-192.40%-86.3M45.04%-31.6M141.84%28.2M-3,480.00%-53.7M394.87%46M267.72%93.4M24.04%-57.5M-503.59%-67.4M-130.61%-1.5M
-Change in receivables 57.57%-12.9M-519.05%-17.6M72.90%-11.3M44.94%-89.3M53.98%-21.4M-36.94%-30.4M127.10%4.2M46.54%-41.7M-471.13%-162.2M-114.29%-46.5M
-Change in inventory -213.79%-3.3M-431.25%-5.3M-38.89%1.1M307.69%5.4M-123.08%-900K137.66%2.9M633.33%1.6M20.00%1.8M-4.00%-2.6M178.00%3.9M
-Change in payables and accrued expense -68.33%39.4M-467.28%-59.5M-377.61%-18.6M-43.89%64.3M-320.74%-83M279.27%124.4M-50.46%16.2M-41.74%6.7M101.76%114.6M96.86%37.6M
-Change in other working capital 63.06%-18.8M-105.46%-3.9M88.48%-2.8M377.91%47.8M1,374.29%51.6M-175.14%-50.9M740.00%71.4M-127.10%-24.3M-86.96%-17.2M-72.00%3.5M
Cash from discontinued investing activities
Operating cash flow -25.47%158M-64.03%64.6M204.07%130.3M14.88%389.9M-13.64%123.5M114.57%212M30.05%179.6M-209.14%-125.2M32.32%339.4M3,304.76%143M
Investing cash flow
Cash flow from continuing investing activities 125.39%24.7M77.60%-28.2M-30.64%-55M-163.75%-467.1M-74.57%-201.8M-58.73%-97.3M-500.96%-125.9M-33.23%-42.1M-36.02%-177.1M-587.76%-115.6M
Capital expenditure reported -6.58%-8.1M-70.59%-11.6M-31.76%-11.2M-71.52%-28.3M-200.00%-5.4M-547.06%-7.6M22.73%-6.8M-11.84%-8.5M29.49%-16.5M79.78%-1.8M
Net business purchase and sale --------------0-------------------42.7M----
Net investment purchase and sale 136.57%32.8M86.06%-16.6M-30.36%-43.8M-272.18%-438.8M-176.23%-196.4M-42.38%-89.7M-396.27%-119.1M-40.00%-33.6M-10.39%-117.9M-318.10%-71.1M
Cash from discontinued investing activities
Investing cash flow 125.39%24.7M77.60%-28.2M-30.64%-55M-163.75%-467.1M-74.57%-201.8M-58.73%-97.3M-500.96%-125.9M-33.23%-42.1M-36.02%-177.1M-587.76%-115.6M
Financing cash flow
Cash flow from continuing financing activities 40.43%26.4M-10,203.45%-293M752.44%69.9M127.87%65.3M43.90%35.4M64.91%18.8M101.05%2.9M34.43%8.2M-955.11%-234.3M1,266.67%24.6M
Net issuance payments of debt --0----------0--0--0---------278,900.00%-279M--0
Proceeds from stock option exercised by employees 40.43%26.4M444.83%15.8M752.44%69.9M46.09%65.3M43.90%35.4M64.91%18.8M11.54%2.9M34.43%8.2M62.55%44.7M1,266.67%24.6M
Cash from discontinued financing activities
Financing cash flow 40.43%26.4M-10,203.45%-293M752.44%69.9M127.87%65.3M43.90%35.4M64.91%18.8M101.05%2.9M34.43%8.2M-955.11%-234.3M1,266.67%24.6M
Net cash flow
Beginning cash position -12.19%147.7M262.28%404.3M-4.29%259.1M-21.31%270.7M37.14%301.7M-1.69%168.2M-59.86%111.6M-21.31%270.7M80.77%344M-30.00%220M
Current changes in cash 56.63%209.1M-553.36%-256.6M191.26%145.2M83.47%-11.9M-182.50%-42.9M173.01%133.5M152.95%56.6M-141.06%-159.1M-146.84%-72M75.08%52M
Effect of exchange rate changes ------------123.08%300K--300K---------------1.3M----
End cash Position 18.36%357.1M-12.19%147.7M262.28%404.3M-4.29%259.1M-4.29%259.1M37.14%301.7M-1.69%168.2M-59.86%111.6M-21.31%270.7M-21.31%270.7M
Free cash flow -26.66%149.9M-69.33%53M189.08%119.1M11.99%361.6M-16.36%118.1M103.38%204.4M33.64%172.8M-177.96%-133.7M38.52%322.9M3,104.26%141.2M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion------------
Heat List
US
Overall
Symbol
Price
% Chg

No Data